Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Guggenheim 

BioMarin Pharmaceutical Inc. diskutieren

BioMarin Pharmaceutical Inc.

WKN: 924801 / Symbol: BMRN / Name: BioMarin Pharmaceutical / Aktie / Pharmazeutika / Large Cap /

52,12 €
-0,04 %

26 0
26
0
Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 73,15
Veränderung
Endet am 11.03.27

BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Bank of America Co. 
0
Melden Teilen
11.03.26
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Jefferies_Financial_ in Methanex Corp. diskutieren
Methanex (NASDAQ:MEOH) (TSE:MX) had its price target rais...
11.03.26
Tigress_Financial in Discuss Fiserv Inc.
Fiserv (FISV) had its "buy" rating reaffirmed by Tigress ...
11.03.26
The_Goldman_Sachs_Gr in Occidental Petroleum Corp. diskutieren
Occidental Petroleum (OXY) had its price target raised by...
11.03.26
The_Goldman_Sachs_Gr in Kohl's Corp. diskutieren
Kohl's (KSS) had its price target lowered by The Goldman ...
11.03.26
The_Goldman_Sachs_Gr in Diamondback Energy diskutieren
Diamondback Energy (FANG) had its price target raised by ...
11.03.26
The_Goldman_Sachs_Gr in Discuss Carnival Paired Ctf
Carnival (CCL) had its price target lowered by The Goldma...
11.03.26
BTIG_Research in Uber Technologies Inc diskutieren
Uber Technologies (UBER) had its "buy" rating reaffirmed ...
11.03.26
UBS_Group_AG in Bunge Ltd. diskutieren
Bunge Global (BG) had its "buy" rating reaffirmed by UBS ...
11.03.26
Mehr anzeigen